Correlation Between Rocket Pharmaceuticals and Avidity Biosciences

Can any of the company-specific risk be diversified away by investing in both Rocket Pharmaceuticals and Avidity Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rocket Pharmaceuticals and Avidity Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rocket Pharmaceuticals and Avidity Biosciences, you can compare the effects of market volatilities on Rocket Pharmaceuticals and Avidity Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rocket Pharmaceuticals with a short position of Avidity Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rocket Pharmaceuticals and Avidity Biosciences.

Diversification Opportunities for Rocket Pharmaceuticals and Avidity Biosciences

-0.11

Correlation Coefficient

Rocket Pharmaceuticals  Avidity Biosciences

Good diversification

The 3 months correlation between Rocket and Avidity is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Rocket Pharmaceuticals and Avidity Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avidity Biosciences and Rocket Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rocket Pharmaceuticals are associated (or correlated) with Avidity Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avidity Biosciences has no effect on the direction of Rocket Pharmaceuticals i.e., Rocket Pharmaceuticals and Avidity Biosciences go up and down completely randomly.

Pair Corralation between Rocket Pharmaceuticals and Avidity Biosciences

Given the investment horizon of 90 days Rocket Pharmaceuticals is expected to under-perform the Avidity Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Rocket Pharmaceuticals is 1.07 times less risky than Avidity Biosciences. The stock trades about -0.07 of its potential returns per unit of risk. The Avidity Biosciences is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest  4,099  in Avidity Biosciences on September 2, 2024 and sell it today you would earn a total of  204.00  from holding Avidity Biosciences or generate 4.98% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rocket Pharmaceuticals  vs.  Avidity Biosciences

Rocket Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rocket Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's forward-looking signals remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Avidity Biosciences

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Avidity Biosciences are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Avidity Biosciences may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Rocket Pharmaceuticals and Avidity Biosciences

The main advantage of trading using opposite Rocket Pharmaceuticals and Avidity Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rocket Pharmaceuticals position performs unexpectedly, Avidity Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avidity Biosciences will offset losses from the drop in Avidity Biosciences' long position.

The idea behind Rocket Pharmaceuticals and Avidity Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.